FIMECS
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300 proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
FIMECS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2018-01-18
Address:
Fujisawa, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.fimecs.com
Total Employee:
1+
Status:
Active
Contact:
+81-466-32-1169
Email Addresses:
[email protected]
Total Funding:
810 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Microsoft Exchange Online
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
ANRI
ANRI investment in Series A - Fimecs
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series A - Fimecs
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Series A - Fimecs
Cosmo Bio
Cosmo Bio investment in Seed Round - Fimecs
Takeda
Takeda investment in Seed Round - Fimecs
Official Site Inspections
http://www.fimecs.com
- Host name: sv5145.xserver.jp
- IP address: 202.254.236.146
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
